By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: Cancer Medication Stops Advancement of Disease in Mice
Share
Notification Show More
Latest News
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > Cancer Medication Stops Advancement of Disease in Mice
Health

Cancer Medication Stops Advancement of Disease in Mice

News Room
Last updated: 2024/07/06 at 2:25 PM
News Room
Share
3 Min Read
SHARE

Parkinson’s disease is a complex condition that affects nerve function, movement, and cognitive abilities. Research is ongoing to understand the specific brain changes that occur in the disease and explore potential treatment options. Recent findings published in Nature Communications shed light on the interactions of two proteins, Lag3 and Aplp1, in facilitating the toxicity of the protein alpha-synuclein. By disrupting this interaction with an anti-Lag3 antibody, researchers were able to prevent neurodegeneration in mice, pointing towards a potential way to halt the progression of Parkinson’s disease.

The study revealed that the genetic deletion of Aplp1 and Lag3 helped preserve dopaminergic neurons responsible for dopamine production and eliminate behavior deficits associated with alpha-synuclein. These findings suggest that targeting Lag3 with the FDA-approved cancer drug nivolumab/relatlimab could potentially slow or stop the spread of alpha-synuclein clumps in Parkinson’s disease. Further research is needed to investigate the efficacy and safety of this treatment in human clinical trials, as well as explore additional potential therapies for managing the disease.

Parkinson’s disease impacts individuals differently, with motor symptoms like tremors, rigidity, and slowness of movement, as well as nonmotor symptoms such as cognitive decline, mood disorders, and sleep disturbances. As the disease progresses, patients may experience a decline in quality of life, increased dependence on caregivers, and emotional and financial challenges for both patients and their families. Understanding the underlying mechanisms of Parkinson’s disease and developing targeted treatments is crucial to improving outcomes and quality of life for those affected by the condition.

Current treatment for Parkinson’s disease focuses on symptom management through therapy, medication, and lifestyle modifications. While there is no cure for the disease, ongoing research like the recent study on Lag3 and Aplp1 interactions offers promising insights into potential therapeutic strategies. By targeting specific proteins involved in alpha-synuclein toxicity, researchers aim to halt neurodegeneration and improve outcomes for individuals living with Parkinson’s disease.

The study authors emphasize the importance of further research to validate the effectiveness of targeting Lag3 with an anti-Lag3 antibody in mouse models of Parkinson’s and Alzheimer’s diseases. Clinical trials will be essential to assess the safety and efficacy of this treatment in humans and explore other potential approaches for preventing the release and uptake of disease-causing alpha-synuclein clumps in the brain. Collaborative efforts in the scientific community are essential to advancing our understanding of Parkinson’s disease and developing innovative therapies to address its complex nature.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room July 6, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Summer in the UAE: Workers receive free health check-ups and gifts in new campaign
Next Article French Ambassador Welcomes Bahraini Paralympic Delegation with Open Arms
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World June 28, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?